Yanping Ye

Director Técnico/Científico/I+D en Continent Pharmaceutical Inc. .

41 años

Health Technology

Consumer Services

Perfil

Yanping Ye is currently the Director of Research at Continent Pharmaceutical Inc. Prior to this, Dr. Ye worked as the Director of Research & Development at Shanghai Genomics, Inc. from 2016 to 2018.
Dr. Ye earned a doctorate degree from Portland State University in 2012.

Cargos activos de Yanping Ye

Empresas	Cargo	Inicio
Continent Pharmaceutical Inc. Continent Pharmaceutical Inc. Pharmaceuticals: MajorHealth Technology Continent Pharmaceutical Inc. operates as orphan drug company. It develops, manufactures and distributes pharmaceutical products for the treatment of organ fibrosis and other orphan diseases. Its products includes ETUARY and generic drugs. The company was founded on July 3, 2002 and is headquartered in Beijing, China.	Director Técnico/Científico/I+D	01/08/2018

Todos los cargos activos de Yanping Ye

Antiguos cargos conocidos de Yanping Ye.

Empresas	Cargo	Fin
Shanghai Genomics, Inc. Shanghai Genomics, Inc. Pharmaceuticals: MajorHealth Technology Part of GNI Group Ltd., Shanghai Genomics, Inc. engages in therapeutic pharmaceutical products development and production. The company is based in Shanghai, China. Shanghai Genomics was acquired by GNI Group Ltd. on June 20, 2005. The Chinese company was founded by Ying Luo, Jun Wu.	Director Técnico/Científico/I+D	01/07/2018

Ver el detalle de la experiencia de Yanping Ye.

Formación de Yanping Ye.

Portland State University

Doctorate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Yanping Ye.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	2
Continent Pharmaceutical Inc. Continent Pharmaceutical Inc. Pharmaceuticals: MajorHealth Technology Continent Pharmaceutical Inc. operates as orphan drug company. It develops, manufactures and distributes pharmaceutical products for the treatment of organ fibrosis and other orphan diseases. Its products includes ETUARY and generic drugs. The company was founded on July 3, 2002 and is headquartered in Beijing, China.	Health Technology
Shanghai Genomics, Inc. Shanghai Genomics, Inc. Pharmaceuticals: MajorHealth Technology Part of GNI Group Ltd., Shanghai Genomics, Inc. engages in therapeutic pharmaceutical products development and production. The company is based in Shanghai, China. Shanghai Genomics was acquired by GNI Group Ltd. on June 20, 2005. The Chinese company was founded by Ying Luo, Jun Wu.	Health Technology